Pathologic Complete Response clinical trials
The registry lists 79 studies for Pathologic Complete Response across more than 10 countries. 40 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Recruiting
- 27
- Completed
- 17
- Not yet recruiting
- 13
- Active, not recruiting
- 8
- Terminated
- 7
- Status unknown
- 2
Phase
- Phase 2
- 30
- Phase 3
- 11
- Phase 1
- 10
- Early Phase 1
- 1
- Phase 4
- 1
Where
- United States
- 27
- China
- 26
- France
- 10
- Australia
- 6
- Canada
- 6
- Netherlands
- 5
Who runs them
Tang-Du Hospital (3) · Sixth Affiliated Hospital, Sun Yat-sen University (3) · Shanghai Pulmonary Hospital, Shanghai, China (2) · Ming-Yuan Chen (2) · National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (2) · Astellas Pharma Global Development, Inc. (2) · Peking University People's Hospital (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 79 — search for more.
- Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBCRecruitingNCT07066189Not applicable1 country
- Perioperative Adebrelimab for Locally Advanced Cervical CancerNot yet recruitingNCT07811375Phase 21 country
- Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With Chemoimmunotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma：A Prospective Single-Arm, Phase II StudyRecruitingNCT07808853Phase 21 country
- Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell CarcinomaRecruitingNCT067555671 country
- Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck CancerNot yet recruitingNCT07780877Phase 21 country
- Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot StudyNot yet recruitingNCT06743555Phase 11 country
- Supervised Exercise During Neoadjuvant Chemotherapy for Breast CancerNot yet recruitingNCT07764341Not applicable1 country
- Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCRecruitingNCT07754812Phase 41 country
- Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal CarcinomaNot yet recruitingNCT07752394Phase 21 country
- Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer PatientsRecruitingNCT05350722Not applicable2 countries
- Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm PatientsRecruitingNCT07007052Phase 21 country
- Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical CancerNot yet recruitingNCT07673211
- Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell CarcinomaNot yet recruitingNCT07618793Phase 21 country
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 21 country
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 21 country
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingNCT01042379Phase 21 country
- Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal CarcinomaNot yet recruitingNCT07538206Phase 1/2
- Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal CancerNot yet recruitingNCT07472868Phase 31 country
- Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）RecruitingNCT06647680Phase 21 country
- Relugolix + Enzalutamide Study in High-Risk Prostate CancerRecruitingNCT06130995Phase 11 country
- Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell CarcinomaRecruitingNCT07430579Not applicable1 country
- NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUCNot yet recruitingNCT07412171Phase 21 country
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable1 country
- Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal CancerNot yet recruitingNCT07397442Phase 21 country
- Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar CancerRecruitingNCT07353723Phase 21 country
- T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CRRecruitingNCT073538401 country
- Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and ImmunotherapyRecruitingNCT07328841Phase 31 country
- 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal CarcinomaRecruitingNCT07328854Phase 31 country
- Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal CancerRecruitingNCT063643711 country
- Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast CancerNot yet recruitingNCT07164872Not applicable
- Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast CancerRecruitingNCT071661851 country
- Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCRecruitingNCT06811844Phase 21 country
- DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic TherapyRecruitingNCT05416164Not applicable1 country
- Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant TherapyNot yet recruitingNCT068894021 country
- Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia PatientsRecruitingNCT04314219Phase 31 country
- Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant ChemotherapyRecruitingNCT06299202Not applicable1 country
- The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPCRecruitingNCT061826571 country
- Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerRecruitingNCT059257511 country
- Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric AdenocarcinomaRecruitingNCT05563012Phase 21 country
- Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal CancerRecruitingNCT04018872Phase 21 country
- Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT06694454Phase 1/21 country
- Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)Active, not recruitingNCT02386670Not applicable1 country
- Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary TreatmentActive, not recruitingNCT059260241 country
- Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid TumorsActive, not recruitingNCT03832569Early Phase 11 country
- Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma RelapseTerminatedNCT01794572Not applicable1 country
- Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.Active, not recruitingNCT01844986Phase 315 countries
- Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2Active, not recruitingNCT04229979Phase 310 countries
- NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 32 countries
- Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.CompletedNCT06996301Not applicable1 country
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruitingNCT06087718Not applicable1 country